Picture of Shin Nippon Biomedical Laboratories logo

2395 — Shin Nippon Biomedical Laboratories News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Table: Shin Nippon Biomedical - 6-MTH group results

Nov 14 (Reuters)-  
             Shin Nippon Biomedical Laboratories Ltd  
             CONSOLIDATED FINANCIAL HIGHLIGHTS  
     (in billions of yen unless specified)                 
                 6 months ended      6 months ended        Year to   
                Sep 30, 2017        Sep 30, 2016      Mar 31, 2018   
                   LATEST             YEAR-AGO           LATEST      
                   RESULTS             RESULTS          FORECAST     
  Sales             7.55                7.08              16.25      
                 (+6.6 pct)          (+7.9 pct)        (-5.8 pct)    
  Operating     loss 779 mln          loss 1.71         loss 1.10    
  Recurring     loss 640 mln          loss 2.91         loss 1.22    
  Net             loss 1.65           loss 2.89         loss 1.50    
  EPS          loss 39.63 yen      loss 70.66 yen    loss 36.02 yen  
  Ann Div                                NIL                         
  -Q2 div            NIL                 NIL                         
  -Q4 div                                NIL                         
   
  NOTE - Shin Nippon Biomedical Laboratories Ltd.  
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=2395.T  
  ((Tokyo Headline News Desk +813 6441 1812))

Recent news on Shin Nippon Biomedical Laboratories

See all news